Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Arthritis Rheum. 2012 Jan 9;64(6):1899–1908. doi: 10.1002/art.34370

Figure 1.

Figure 1

A: Representative safranin-O stained sagittal sections of femoral articular cartilage in saline control and MIA-injected knees at 1, 2, and 3 weeks post-injection. B-C: EPIC-µCT images of cartilage X-ray attenuation (sagittal slices), cartilage thickness maps, and standard µCT images of subchondral and trabecular bone in distal femora at 1 week (B) and 3 weeks (C) after injections of MIA to induce OA and saline for contralateral controls.